T.A. Sciences, Inc. For Profit
.jpg)
Aegle Therapeutics is a clinical stage regenerative medicine company that develops novel therapeutics.
Technology:
Other
Industry:
Regenerative medicine
Headquarters:
United States
Investors Number:
8
Total Funding:
$82.7M
Estimated Revenue:
Less than $1M
Last Funding Type:
Series D
Register and Claim Ownership